Total Payments
$17,573
2024 Payments
$1,061
Companies
48
Transactions
352
Medicare Patients
3,406
Medicare Billing
$773,790
Payment Breakdown by Category
Food & Beverage$7,568 (43.1%)
Other$4,500 (25.6%)
Consulting$4,495 (25.6%)
Travel$1,008 (5.7%)
Education$2.56 (0.0%)
Gifts$0.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,568 | 339 | 43.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 2 | 25.6% |
| Consulting Fee | $4,495 | 2 | 25.6% |
| Travel and Lodging | $1,008 | 6 | 5.7% |
| Education | $2.56 | 1 | 0.0% |
| Gift | $0.02 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INSYS Therapeutics Inc | $10,186 | 41 | $0 (2018) |
| Abbott Laboratories | $1,023 | 21 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $947.97 | 60 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $599.53 | 34 | $0 (2024) |
| Medtronic, Inc. | $540.52 | 13 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $492.98 | 33 | $0 (2024) |
| Relievant Medsystems, Inc. | $486.66 | 5 | $0 (2022) |
| Forte Bio-Pharma LLC | $380.10 | 17 | $0 (2024) |
| SPR Therapeutics, Inc | $344.11 | 9 | $0 (2024) |
| Egalet US Inc | $237.81 | 39 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,061 | 46 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($383.94) |
| 2023 | $1,231 | 38 | SPR Therapeutics, Inc ($286.31) |
| 2022 | $1,376 | 41 | Relievant Medsystems, Inc. ($486.66) |
| 2021 | $498.44 | 28 | SCILEX PHARMACEUTICALS INC. ($139.40) |
| 2020 | $935.12 | 46 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($216.79) |
| 2019 | $575.12 | 25 | Amgen Inc. ($120.65) |
| 2018 | $1,108 | 34 | Abbott Laboratories ($784.04) |
| 2017 | $10,788 | 94 | INSYS Therapeutics Inc ($10,163) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $9.54 | General |
| 11/20/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $7.65 | General |
| Category: Pain management | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/31/2024 | Forte Bio-Pharma LLC | PROLATE (Drug), NALOCET, PROLATE | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Gastroenterology | ||||||
| 09/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Analgesic | ||||||
| 08/23/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/22/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Not Applicable | ||||||
| 08/22/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Not Applicable | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Gastroenterology | ||||||
| 08/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Opioid Analgesic | ||||||
| 08/08/2024 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| 08/05/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $27.43 | General |
| Category: Pain management | ||||||
| 08/03/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,654 | 4,148 | $2.8M | $350,981 |
| 2022 | 20 | 850 | 2,485 | $1.8M | $212,818 |
| 2021 | 15 | 531 | 1,455 | $1.1M | $134,279 |
| 2020 | 11 | 371 | 1,877 | $311,303 | $75,712 |
Total Patients
3,406
Total Services
9,965
Medicare Billing
$773,790
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 196 | 781 | $718,145 | $76,298 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 542 | $349,308 | $39,153 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 364 | $332,470 | $36,105 | 10.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 108 | 140 | $138,275 | $33,732 | 24.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 173 | 194 | $274,256 | $26,663 | 9.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 192 | 357 | $88,736 | $21,705 | 24.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 62 | 99 | $78,701 | $19,282 | 24.5% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 76 | 120 | $75,163 | $18,415 | 24.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 284 | $182,646 | $18,383 | 10.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 35 | 93 | $186,706 | $16,462 | 8.8% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 43 | 64 | $51,622 | $5,876 | 11.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 19 | 29 | $45,345 | $5,620 | 12.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 45 | $43,551 | $4,833 | 11.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $41,251 | $4,693 | 11.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 21 | 22 | $28,906 | $3,386 | 11.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $29,193 | $3,334 | 11.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 14 | 40 | $15,605 | $3,149 | 20.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 19 | 28 | $22,484 | $2,853 | 12.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 41 | $21,559 | $2,486 | 11.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 18 | $12,889 | $2,445 | 19.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 21 | 22 | $19,973 | $2,299 | 11.5% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 13 | 13 | $10,957 | $1,289 | 11.8% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 36 | 40 | $9,534 | $1,085 | 11.4% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 13 | 13 | $7,816 | $918.19 | 11.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 58 | 589 | $5,089 | $500.97 | 9.8% |
About Dr. Bruce Mann, MD
Dr. Bruce Mann, MD is a Anesthesiology healthcare provider based in Tamarac, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285607911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Mann, MD has received a total of $17,573 in payments from pharmaceutical and medical device companies, with $1,061 received in 2024. These payments were reported across 352 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,568).
As a Medicare-enrolled provider, Mann has provided services to 3,406 Medicare beneficiaries, totaling 9,965 services with total Medicare billing of $773,790. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Tamarac, FL
- Active Since 02/13/2006
- Last Updated 06/11/2024
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1285607911
Products in Payments
- SUBSYS (Drug) $10,178
- RELISTOR (Drug) $947.97
- Axium INS DRG IPG (Device) $758.65
- ZTLido (Drug) $503.25
- Intracept (Device) $486.66
- SPRINT PNS System (Device) $344.11
- XTAMPZA (Drug) $265.54
- INTELLIS ADAPTIVESTIM (Device) $230.56
- SYNCHROMEDII (Device) $229.03
- NALOCET (Drug) $185.41
- DYSPORT (Drug) $184.99
- COOLIEF* COOLED RADIOFREQUENCY (Device) $174.89
- mild Device Kit (Device) $166.86
- PAINTEQ (Device) $162.90
- Xtampza ER (Drug) $148.45
- SPRIX (Drug) $141.11
- Nalocet (Drug) $127.90
- Aimovig (Biological) $120.65
- Movantik (Drug) $111.75
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $107.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Tamarac
Eduardo Marti, Md, MD
Anesthesiology — Payments: $101.43
Anesthesiology $101.43
Dr. Bobak Koohian, M.d, M.D
Anesthesiology — Payments: $89.75
Anesthesiology $89.75
Dr. Dwayne Maultsby, Md, MD
Anesthesiology — Payments: $66.00
Anesthesiology $66.00
Dr. Clifford Boehm, M.d, M.D
Anesthesiology — Payments: $30.75
Anesthesiology $30.75
Ramiro Rodriguez, Md, MD
Anesthesiology
Anesthesiology
Kenneth Dacey, Md, MD
Anesthesiology
Anesthesiology